Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-15-000915
Filing Date
2015-04-15
Accepted
2015-04-15 14:35:58
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mjpharmaceuticals10k123114.htm 10-K 728178
2 EX-31 ex31.htm EX-31 11854
3 EX-32 ex32.htm EX-32 7176
10 GRAPHIC logo.jpg GRAPHIC 11004
  Complete submission text file 0001185185-15-000915.txt   2710845

Data Files

Seq Description Document Type Size
4 EX-101.INS mela-20141231.xml EX-101.INS 302390
5 EX-101.SCH mela-20141231.xsd EX-101.SCH 22088
6 EX-101.CAL mela-20141231_cal.xml EX-101.CAL 15095
7 EX-101.DEF mela-20141231_def.xml EX-101.DEF 95069
8 EX-101.LAB mela-20141231_lab.xml EX-101.LAB 126832
9 EX-101.PRE mela-20141231_pre.xml EX-101.PRE 97860
Mailing Address 7524 GLENTURRET CIRCLE C/O UREN ENTERPRISES, LLC THE COLONY TX 75056
Business Address 7524 GLENTURRET CIRCLE C/O UREN ENTERPRISES, LLC THE COLONY TX 75056 214-505-3839
MJ Pharmaceuticals Inc. (Filer) CIK: 0001502629 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54811 | Film No.: 15771389
SIC: 7389 Services-Business Services, NEC